NasdaqHealth CareHealth Care EquipmentS&P SmallCap 600
$88.24
+19.26 (+27.92%)
Close of Nov 06, 2026 · end-of-day data
TMDX 8-K filings in 2024
Every material Form 8-K TransMedics Group filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On December 5, 2024, a wholly-owned subsidiary of TransMedics Group acquired one fixed-wing aircraft from A-JETS CZ, a.s. for approximately $13.9 million. The company says it will use all 19 aircraft it has acquired to date to transport donor organs under its National OCS Program. The filing reports no financial results, so the direct financial effect on shareholders is not quantified beyond the purchase price.
Buyer: TransMedics, Inc., a wholly-owned subsidiary of TransMedics Group, Inc.
Seller: A-JETS CZ, a.s.; purchase date December 5, 2024; price approximately $13.9 million
Fleet total: 19 aircraft acquired to date, including 18 in prior acquisitions
Stated use: transporting donor organs for the National OCS Program
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every TransMedics Group filing is on SEC EDGAR ↗. 8-K briefs of other companies →